Marshall William Stuart 5
5 · MIRAGEN THERAPEUTICS, INC. · Filed Feb 13, 2020
Insider Transaction Report
Form 5
Marshall William Stuart
DirectorPresident & CEO
Transactions
- Award
Common Stock
2019-02-21$2.46/sh+1,250$3,071→ 269,396 total - Award
Common Stock
2019-08-21$1.14/sh+1,250$1,424→ 270,646 total
Footnotes (1)
- [F1]These shares were acquired under the Miragen Therapeutics, Inc. 2016 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).